Skip to content
Friday, October 9, 2026
True Gaming 195

TikTok Content Creators Fueling Unofficial Market for Unlicensed Weight-Loss Drug

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.

Some professionals stated the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Elimination

According to the social media company, the service has taken down problematic content and banned related hashtags and search suggestions. The company stated it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Investigations also found communities with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, populated with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home.

Within moments of entering one community, a seller shared WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, messages display dark colored packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious health risks”.

JM
About the author

James Mclaughlin

Maya Chen is a passionate gaming journalist with over 8 years of experience covering esports and indie game developments, known for her detailed analysis and engaging writing style.

True Gaming 195

Type to search articles.